Appropriate and inappropriate therapies in patients with Brugada syndrome. What to expect? Authors' reply.
作者信息
Dyrbuś Maciej, Gąsior Mariusz, Tajstra Mateusz
机构信息
3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Curie-Sklodowskiej 9, Katowice 41-800, Poland.
出版信息
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad251.
Abstract
摘要
相似文献
1
Appropriate and inappropriate therapies in patients with Brugada syndrome. What to expect? Authors' reply.
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad251.
2
Appropriate and inappropriate therapies in remotely monitored patients with Brugada syndrome: what to expect?
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad167.
3
Feasibility of drugs in Brugada syndrome: Authors' reply.
Europace. 2018 Jun 1;20(FI1):f137. doi: 10.1093/europace/euy002.
4
(Tpeak - Tend)/QRS and (Tpeak - Tend)/(QT × QRS) as risk markers in Brugada syndrome: authors' reply.
Europace. 2017 Apr 1;19(4):696-697. doi: 10.1093/europace/euw210.
5
Brugada electrocardiogram pattern and right bundle branch block: Authors' reply.
Europace. 2019 Jul 1;21(7):1140-1141. doi: 10.1093/europace/euz049.
6
Prediction of ventricular arrhythmias in Brugada syndrome patients: is it time for automatized electrocardiogram analysis?-Authors' reply.
Europace. 2020 Apr 1;22(4):674-675. doi: 10.1093/europace/euaa011.
7
Implantable loop recorders in Brugada syndrome: Authors' reply.
Europace. 2023 Feb 16;25(2):775-776. doi: 10.1093/europace/euac150.
8
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Circulation. 2013 Oct 15;128(16):1739-47. doi: 10.1161/CIRCULATIONAHA.113.001941. Epub 2013 Aug 30.
9
Prevention of inappropriate ICD shocks in patients with Brugada syndrome.
Clin Res Cardiol. 2010 Jan;99(1):37-44. doi: 10.1007/s00392-009-0075-4. Epub 2009 Sep 16.
10
Unsafe Drug Use and Arrhythmic Events in Brugada Patients with ICD: Results of a Long-Term Follow-Up.
Cardiovasc Drugs Ther. 2018 Feb;32(1):23-28. doi: 10.1007/s10557-018-6770-5.
本文引用的文献
1
Appropriate and inappropriate therapies in remotely monitored patients with Brugada syndrome: what to expect?
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad167.
2
Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review.
Heart Lung. 2023 Jul-Aug;60:1-7. doi: 10.1016/j.hrtlng.2023.02.012. Epub 2023 Feb 28.
3
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
4
Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome.
Heart Rhythm. 2023 Feb;20(2):274-281. doi: 10.1016/j.hrthm.2022.09.016. Epub 2022 Sep 24.
5
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
6
Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD.
Front Cardiovasc Med. 2022 Jul 22;9:964694. doi: 10.3389/fcvm.2022.964694. eCollection 2022.
7
Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up.
Clin Cardiol. 2019 Oct;42(10):958-965. doi: 10.1002/clc.23247. Epub 2019 Aug 22.
8
COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry.
Kardiol Pol. 2016;74(6):523-8. doi: 10.5603/KP.a2015.0224. Epub 2015 Nov 24.
Zotero 插件